Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use
Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.
Tasmanian Health 22072002
ANZCA-response-to-ANZCOR-guideline-4-Airway-20210127
Tasmanian Health Service NWRH April 2021
ANZCA-response-to-TGA-repurposing-medicines-consultation-20210330
DRGA-Media-Release-290921
ANZCA feedback on liposuction guideline
25 February 2022 letter to Kay Martin, Senior Nurse Advisor, Private Hospitals & NEPT Regulation
Victorian Department of Health
Adrenaline-Link PFS Safety Update Nov 2017
Safety update from Link on connector incompatibility issues with a pre-filled adrenaline syringe product.